ஆரோக்கியம் அறிவியல் அதிகாரம் ஆஃப் சிங்கப்பூர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆரோக்கியம் அறிவியல் அதிகாரம் ஆஃப் சிங்கப்பூர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆரோக்கியம் அறிவியல் அதிகாரம் ஆஃப் சிங்கப்பூர் Today - Breaking & Trending Today

GSK Singapore and Vir Biotechnology Announce Advance Purchase Agreement with the Government of Singapore for Monoclonal Antibody Sotrovimab (VIR-7831)


June 29, 2021
GSK Singapore has signed an Advance Purchase Agreement with the Government of Singapore for sotrovimab
Sotrovimab is currently undergoing review by the Singapore Health Sciences Authority (HSA) under the Pandemic Special Access Route (PSAR) for interim authorization
Announcement follows the emergency use authorization (EUA) granted to sotrovimab by the US Food and Drug Administration (FDA) and a positive scientific opinion by the European Medicines Agency s (EMA) Committee for Medicinal Products for Human Use (CHMP)  
SINGAPORE, June 30, 2021 /PRNewswire/  GlaxoSmithKline Singapore and Vir Biotechnology announced an agreement with the Government of Singapore for the supply of sotrovimab, an investigational single-dose monoclonal antibody, for the treatment of patients with COVID-19 who do not require oxygen supplementation and who are at risk of progressing to severe COVID-19.  ....

Mike Crichton , Singapore Health Sciences Authority , Health Sciences Authority Of Singapore , European Medicines Agency , Drug Administration , Committee For Medicinal Products Human Use , Advance Purchase Agreement , Pandemic Special Access Route , Medicinal Products , Human Use , Glaxosmithkline Singapore , Vir Biotechnology , Primary Care Therapy Area , Phil Pang , Health Sciences Authority , Efficacy Trial , Care Early , Emergency Use Authorization , மைக் கிரிக்டன் , சிங்கப்பூர் ஆரோக்கியம் அறிவியல் அதிகாரம் , ஆரோக்கியம் அறிவியல் அதிகாரம் ஆஃப் சிங்கப்பூர் , குழு க்கு மருத்துவ ப்ராடக்ட்ஸ் மனிதன் பயன்பாடு , சர்வதேச பரவல் சிறப்பு நுழைவு பாதை , மருத்துவ ப்ராடக்ட்ஸ் , மனிதன் பயன்பாடு , வீர் உயிரி தொழில்நுட்பவியல் ,

Questions arise over diabetes drug recall


Questions arise over diabetes drug recall
14:30 | 10/03/2021
Following serious warnings among health agencies about possible cancer risks caused by the use of diabetes drug metformin, domestic and international pharmaceutical firms are being questioned over their code of ethics and being urged to take action in order to protect people’s health.
“Worried and scared” were the first emotions mentioned by Mai Nguyen, a 54-year-old woman living in the Linh Dam residential area in Hanoi, when she heard that a batch of metformin tablets had been recalled in the United States because they contain high levels of cancer-causing contaminant N-nitrosodimethylamine (NDMA) – and Vietnamese authorities were following suit with enquiries into batches in this country. ....

United States , Ho Chi Minh City , H Chíinh , Republic Of , Binh Duong , Qu Ng Nam , Han I , Mai Nguyen , Merck Sante , Drug Administration Of Vietnam , Health Sciences Authority Of Singapore , Us Food Drug Administration , Ministry Of Health , National Institute Of Drug Quality , Health Canada , Linh Dam , Drug Administration , National Institute , Drug Quality Control , Zuellig Pharma , Pharma Vietnam , Metformin Stada , Stada Vietnam , Health Sciences Authority , Diabetes Drug , Pharmaceutical Firms ,